Intravenous Zanamivir: A Viable Option for Critically Ill Patients With Influenza.

CONCLUSIONS: The available information suggests that the intravenous formulation of zanamivir offers a viable alternative treatment for critically ill patients with influenza, especially when resistance to other agents is present.
PMID: 33016090 [PubMed - as supplied by publisher]

Source: The Annals of Pharmacotherapy - October 4, 2020 Category: Drugs & Pharmacology Authors: Slain D Tags: Ann Pharmacother Source Type: research